x3 convertible notes, page-31

It appears that this is exactly what they do!
They loan money, then convert the "dollar value" to shares at an 18% discount and then sell out. Any extra profit generated by an increased share price is just an additional "windfall". In this particular case, you can see why they "took the money and ran".
Their approach is all very short-term. They have no interest in becoming a major or majoity sharehold of some biotech company, even if long-term they might have made more money. Basically, sophisticated loan-sharks!!!
Cheers